We are live on ! Find out more
TA

TLS Advisors Portfolio holdings

AUM $42.1M
1-Year Est. Return 25.99%
This Fund
S&P 500
This Quarter Est. Return
-6.43%
1 Year Est. Return
+25.99%
3 Year Est. Return
+65.03%
5 Year Est. Return
10 Year Est. Return
AUM
$43.7M
AUM Growth
-$3.59M
Cap. Flow
+$258K
Cap. Flow %
0.59%
Top 10 Hldgs %
94.53%
Holding
20
New
1
Increased
3
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
VAL icon
Valaris
VAL
+$1.35M
2
BHP icon
BHP
BHP
+$1.09M
3
VALE icon
Vale
VALE
+$1.02M
4
XLB icon
State Street Materials Select Sector SPDR ETF
XLB
+$357K

Top Sells

Rank Stock Value
1
EQT icon
EQT Corp
EQT
+$1.95M
2
NUE icon
Nucor
NUE
+$1.2M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$272K
4
OVID icon
Ovid Therapeutics
OVID
+$101K
5
XOMA
Xoma
XOMA
+$20.5K

Sector Composition

Rank Sector Weight
1 Materials 45.55%
2 Energy 22.67%
3 Communication Services 14.18%
4 Healthcare 13.63%
5 Consumer Discretionary 1.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHP icon
1
BHP
BHP
$215B
$8.59M 19.64%
175,960
+20,000
+13% +$1.09M
EQT icon
2
EQT Corp
EQT
$33.8B
$6.95M 15.9%
150,800
-47,400
-24% -$1.95M
META icon
3
Meta Platforms (Facebook)
META
$1.59T
$6.2M 14.18%
10,589
RIO icon
4
Rio Tinto
RIO
$150B
$6.06M 13.86%
103,100
VALE icon
5
Vale
VALE
$63.2B
$5.27M 12.05%
594,000
+100,000
+20% +$1.02M
XOMA
6
DELISTED
Xoma
XOMA
$3.13M 7.15%
119,044
-700
-0.6% -$20.5K
RRC icon
7
Range Resources
RRC
$9.06B
$1.72M 3.94%
47,923
XENE icon
8
Xenon Pharmaceuticals
XENE
$6.4B
$1.29M 2.95%
32,956
VAL icon
9
Valaris
VAL
$5.46B
$1.24M 2.83%
+28,000
New +$1.35M
OABI icon
10
OmniAb
OABI
$306M
$886K 2.03%
250,185
OVID icon
11
Ovid Therapeutics
OVID
$444M
$636K 1.45%
680,967
-90,564
-12% -$101K
HOV icon
12
Hovnanian Enterprises
HOV
$771M
$518K 1.18%
3,872
XLB icon
13
State Street Materials Select Sector SPDR ETF
XLB
$8.43B
$501K 1.15%
11,900
+7,700
+183% +$357K
WY icon
14
Weyerhaeuser
WY
$17.2B
$422K 0.96%
15,000
EWS icon
15
iShares MSCI Singapore ETF
EWS
$1.03B
$297K 0.68%
13,600
ENZ
16
DELISTED
Enzo Biochem, Inc.
ENZ
$10K 0.02%
13,616
RVP icon
17
Retractable Technologies
RVP
$20.4M
$8K 0.02%
12,152
NUE icon
18
Nucor
NUE
$53.7B
-8,000
Closed -$1.2M
REGN icon
19
Regeneron Pharmaceuticals
REGN
$68.3B
-259
Closed -$272K
NBIS
20
Nebius Group N.V.
NBIS
$55.4B
-17,811
Closed

Similar funds

TLS Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, TLS Advisors held 20 positions worth $43.7M, down 7.6% from $47.3M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

TLS Advisors's Q4 2024 filing shows 1 new, 3 increased, 3 reduced and 3 closed positions. Its largest new stake was Valaris: 28,000 shares worth $1.24M. The largest sale was EQT Corp, an estimated $1.95M.

By sector, the portfolio is most concentrated in Materials at 46% of assets, down from 51% a quarter earlier, followed by Energy and Communication Services.

  • TLS Advisors's largest Q4 2024 buy was Valaris: 28,000 shares worth $1.24M.
  • TLS Advisors added most to BHP in Q4 2024, an estimated $1.09M increase.
  • TLS Advisors's biggest Q4 2024 reduction was EQT Corp, cutting an estimated $1.95M.
  • TLS Advisors fully exited Nucor in Q4 2024, selling an estimated $1.2M.
  • TLS Advisors's ten largest holdings make up 95% of its $43.7M portfolio in Q4 2024.
  • TLS Advisors opened 1 new position and closed 3 in Q4 2024.
  • TLS Advisors's portfolio value fell 7.6% quarter-over-quarter to $43.7M.

Based on TLS Advisors's 13F filing for Q4 2024, filed 12 Feb 2025.